Advances in and Perspectives on Transgenic Technology and CRISPR-Cas9 Gene Editing in Broccoli

被引:2
|
作者
Zhang, Li [1 ,2 ]
Meng, Sufang [1 ]
Liu, Yumei [1 ]
Han, Fengqing [1 ]
Xu, Tiemin [1 ,3 ]
Zhao, Zhiwei [3 ]
Li, Zhansheng [1 ,3 ]
机构
[1] Chinese Acad Agr Sci, Inst Vegetables & Flowers, State Key Lab Vegetable Biobreeding, Beijing 100081, Peoples R China
[2] Shanxi Agr Univ, Coll Hort, Taigu 030801, Peoples R China
[3] CAAS, Shouguang R&D Ctr Vegetables, Shouguang 262700, Peoples R China
关键词
broccoli; advances; gene editing; CRISPR-Cas9; Agrobacterium-mediated transformation; L; VAR; ITALICA; INTERGENERIC SOMATIC HYBRIDIZATION; CYTOPLASMIC MALE-STERILITY; PROSTATE-CANCER CELLS; BRASSICA-OLERACEA; DOWNY MILDEW; MOLECULAR CHARACTERIZATION; MEDIATED TRANSFORMATION; MESOPHYLL PROTOPLASTS; TRANSIENT TRANSFORMATION;
D O I
10.3390/genes15060668
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Broccoli, a popular international Brassica oleracea crop, is an important export vegetable in China. Broccoli is not only rich in protein, vitamins, and minerals but also has anticancer and antiviral activities. Recently, an Agrobacterium-mediated transformation system has been established and optimized in broccoli, and transgenic transformation and CRISPR-Cas9 gene editing techniques have been applied to improve broccoli quality, postharvest shelf life, glucoraphanin accumulation, and disease and stress resistance, among other factors. The construction and application of genetic transformation technology systems have led to rapid development in broccoli worldwide, which is also good for functional gene identification of some potential traits in broccoli. This review comprehensively summarizes the progress in transgenic technology and CRISPR-Cas9 gene editing for broccoli over the past four decades. Moreover, it explores the potential for future integration of digital and smart technologies into genetic transformation processes, thus demonstrating the promise of even more sophisticated and targeted crop improvements. As the field continues to evolve, these innovations are expected to play a pivotal role in the sustainable production of broccoli and the enhancement of its nutritional and health benefits.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    Papizan, James B.
    Porter, Shaina N.
    Sharma, Akshay
    Pruett-Miller, Shondra M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (02): : 115 - 134
  • [42] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Meisel, Roland
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23):
  • [43] Modelling the Cancer Phenotype in the Era of CRISPR-Cas9 Gene Editing
    Stewart, J.
    Banerjee, S.
    Pettitt, S. J.
    Lord, C. J.
    CLINICAL ONCOLOGY, 2020, 32 (02) : 69 - 74
  • [44] CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
    Blenke, Erik Oude
    Evers, Martijn J. W.
    Mastrobattista, Enrico
    van der Oost, John
    JOURNAL OF CONTROLLED RELEASE, 2016, 244 : 139 - 148
  • [45] Recent Progress in Regulating CRISPR-Cas9 System for Gene Editing
    Gong Shaohua
    Li Na
    Tang Bo
    ACTA CHIMICA SINICA, 2020, 78 (07) : 634 - 641
  • [46] Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing?
    Ahmadi, Fatemeh
    Quach, Angela B. V.
    Shih, Steve C. C.
    BIOMICROFLUIDICS, 2020, 14 (06)
  • [47] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    James B.Papizan
    Shaina N.Porter
    Akshay Sharma
    Shondra M.Pruett-Miller
    The Journal of Biomedical Research, 2021, 35 (02) : 115 - 134
  • [48] The Potential Harms of Human Gene Editing Using CRISPR-Cas9
    Baylis, Francoise
    CLINICAL CHEMISTRY, 2018, 64 (03) : 489 - 491
  • [49] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Lakshmi, Dhanya N.
    INDIAN PEDIATRICS, 2022, 59 (06) : 458 - 458
  • [50] Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
    Zhou, Lifang
    Yao, Shaohua
    MOLECULAR BIOMEDICINE, 2023, 4 (01):